Covered recipient · General Payments record
MANUJ K NANGIA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$7,219.36
- Reported across 385 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.75 | 15 |
| Education | $119.94 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $184.78 | 4 |
| ABBVIE INC. | $154.82 | 8 |
| Masimo Corporation | $49.96 | 2 |
| Indivior Inc. | $34.74 | 2 |
| E.R. Squibb & Sons, L.L.C. | $21.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.44 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098533 | CMS |
| ABBVIE INC. | $27.69 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098535 | CMS |
| ABBVIE INC. | $20.02 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098537 | CMS |
| ABBVIE INC. | $15.88 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098539 | CMS |
| ABBVIE INC. | $18.60 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098541 | CMS |
| ABBVIE INC. | $22.12 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098543 | CMS |
| ABBVIE INC. | $8.45 | 11/13/2024 | Education | Undisputed | 01/23/2026 | 1105098545 | CMS |
| ABBVIE INC. | $9.62 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105098547 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.39 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101390332 | CMS |
| Indivior Inc. | $19.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144534193 | CMS |
| Indivior Inc. | $15.41 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144534195 | CMS |
| Masimo Corporation | $28.01 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152315454 | CMS |
| Masimo Corporation | $21.95 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152315598 | CMS |
| Teva Pharmaceuticals USA, Inc. | $35.46 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151603083 | CMS |
| Teva Pharmaceuticals USA, Inc. | $111.49 | 09/21/2024 | Education | Undisputed | 01/23/2026 | 1151603077 | CMS |
| Teva Pharmaceuticals USA, Inc. | $7.36 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151603087 | CMS |
| Teva Pharmaceuticals USA, Inc. | $30.47 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151603089 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.